Ionis Pharmaceuticals (IONS) Free Cash Flow Growth (5y) (2014 - 2026)
Ionis Pharmaceuticals (IONS) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.27 Bn | 7.36 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.56% |
| Dec 31, 2025 | -25.90% |
| Sep 30, 2025 | -44.01% |
| Jun 30, 2025 | 33.63% |
| Mar 31, 2025 | -80.63% |
| Dec 31, 2024 | -20.35% |
| Sep 30, 2024 | -34.01% |
| Jun 30, 2024 | -32.29% |
| Mar 31, 2024 | -28.31% |
| Dec 31, 2023 | -21.88% |
| Sep 30, 2023 | -40.06% |
| Jun 30, 2023 | -17.31% |
| Mar 31, 2023 | -72.67% |
| Dec 31, 2022 | -64.42% |
| Sep 30, 2022 | -22.74% |
| Jun 30, 2022 | -40.94% |
| Mar 31, 2022 | -18.00% |
| Dec 31, 2021 | 61.34% |
| Sep 30, 2021 | -35.30% |
| Jun 30, 2021 | -12.97% |